My clinical pharmacy research interests include: anemia and bone disease management in the chronic kidney disease (CKD) population, specifically investigating newer agents being utilized to treat these disease states and protocol driven practices. Another area of my pharmacy practice research in nephrology is vascular access. Areas of research include access related infections, specifically understanding infection rates, organisms involved and locking devices for catheters and their clinical outcomes. Furthermore, dialysis modalities have evolved and the pharmacokinetics of drugs has also changed. Therefore much of my research has focused on drug clearance with these newer modalities. Lastly, another area of my research is pharmacy practice research. Here we have investigated different pharmacy services for the dialysis patient and outcomes. I have been the lead investigator on a number of research projects in these areas. Please refer to list of publications for the scope of my clinical research.
Ann Pharmacother. 2018 Oct 20;:1060028018809695
The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients.
Br J Dermatol. 2018 Sep 29;:
A Province-wide, Cross-sectional Study of Demographics and Medication Use of Patients in Hemodialysis Units Across Ontario.
Can J Kidney Health Dis. 2018;5:2054358118760832
A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
Nephrol Dial Transplant. 2018 Mar 02;:
Br J Dermatol. 2018 Jan 08;:
CANNT J. 2014 Oct-Dec;24(4):19-22
CANNT J. 2014 Jul-Sep;24(3):20-2
CANNT J. 2017 Jan-Mar;27(1):19-22
J Eur Acad Dermatol Venereol. 2017 Nov 08;:
Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes.
Can J Kidney Health Dis. 2017;4:2054358117735532